MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness
August 25, 2020 07:00 ET
|
Vericel Corporation
YAVNE, Israel and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the...
Vericel Reports Second Quarter 2020 Financial Results
August 05, 2020 08:00 ET
|
Vericel Corporation
Product Revenues of $20.0 Million Reported for the Second Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation...
Vericel to Report Second-Quarter 2020 Financial Results on August 5, 2020
July 22, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates
July 09, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced...
Vericel Announces Submission of Biologics License Application to the FDA for NexoBrid for the Treatment of Severe Thermal Burns
June 30, 2020 07:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
Vericel to Present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020
May 13, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Reports First Quarter 2020 Financial Results
May 05, 2020 08:00 ET
|
Vericel Corporation
Product Revenues of $26.7 Million Increase 22% Over First Quarter 2019 Positive Cash Flow for the Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 05, 2020 (GLOBE...
Vericel to Report First-Quarter 2020 Financial Results on May 5, 2020
April 22, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel Announces Change to a Virtual Meeting Format For 2020 Annual Meeting of Shareholders
April 10, 2020 09:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 10, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that as a...
Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020
April 08, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...